# Study About Treatment of Newly Diagnosed Non Cutaneous Peripheral T Cell Lymphoma

> **NCT00970385** · PHASE3 · COMPLETED · sponsor: **University Hospital, Grenoble** · enrollment: 95 (actual)

## Conditions studied

- Peripheral T Cell Lymphoma

## Interventions

- **DRUG:** CHOP21
- **DRUG:** VIP/ABVD
- **RADIATION:** Radiotherapy consolidation

## Key facts

- **NCT ID:** NCT00970385
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-01
- **Primary completion:** 2002-12
- **Final completion:** 2008-09
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2009-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00970385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00970385, "Study About Treatment of Newly Diagnosed Non Cutaneous Peripheral T Cell Lymphoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00970385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*